tiprankstipranks
Trending News
More News >
Biotage AB (SE:BIOT)
:BIOT
Sweden Market

Biotage AB (BIOT) Stock Forecast & Price Target

Compare
0 Followers
See the Price Targets and Ratings of:

BIOT Financial Forecast

BIOT Earnings Forecast

Next quarter’s earnings estimate for BIOT is kr0.70 with a range of kr0.34 to kr1.04. The previous quarter’s EPS was kr0.62. BIOT beat its EPS estimate 50.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.44% of the time in the same period. In the last calendar year BIOT has Outperformed its overall industry.
Next quarter’s earnings estimate for BIOT is kr0.70 with a range of kr0.34 to kr1.04. The previous quarter’s EPS was kr0.62. BIOT beat its EPS estimate 50.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.44% of the time in the same period. In the last calendar year BIOT has Outperformed its overall industry.

BIOT Sales Forecast

Next quarter’s sales forecast for BIOT is kr461.93M with a range of kr394.00M to kr503.80M. The previous quarter’s sales results were kr385.00M. BIOT beat its sales estimates 25.00% of the time in past 12 months, while its overall industry beat sales estimates 47.68% of the time in the same period. In the last calendar year BIOT has Outperformed its overall industry.
Next quarter’s sales forecast for BIOT is kr461.93M with a range of kr394.00M to kr503.80M. The previous quarter’s sales results were kr385.00M. BIOT beat its sales estimates 25.00% of the time in past 12 months, while its overall industry beat sales estimates 47.68% of the time in the same period. In the last calendar year BIOT has Outperformed its overall industry.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Danske Bank Analyst forecast on SE:BIOT
Unknown Analyst
Not Ranked
Danske Bank
kr143
Hold
0.92%
Upside
Downgraded
04/23/25
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Danske Bank Analyst forecast on SE:BIOT
Unknown Analyst
Not Ranked
Danske Bank
kr143
Hold
0.92%
Upside
Downgraded
04/23/25
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Biotage AB

Currently, no data available
Please return soon. This page is being updated.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

BIOT Analyst Recommendation Trends

Rating
May 23
Jun 23
Sep 23
Oct 23
Jan 24
Strong Buy
3
2
3
4
4
Buy
0
0
0
0
0
Hold
1
1
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
4
3
3
4
4
In the current month, BIOT has received 4 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. BIOT average Analyst price target in the past 3 months is 143.02.
Each month's total comprises the sum of three months' worth of ratings.

BIOT Stock Forecast FAQ

What is SE:BIOT’s average 12-month price target, according to analysts?
Based on analyst ratings, Biotage AB’s 12-month average price target is 143.02.
    What is SE:BIOT’s upside potential, based on the analysts’ average price target?
    Biotage AB has 0.93% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Biotage AB a Buy, Sell or Hold?
          Biotage AB has a consensus rating of Hold, which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
            What is Biotage AB’s share price target?
            The average share price target for Biotage AB is 143.02. This is based on 0 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is kr143.02 ,and the lowest forecast is kr143.02. The average share price target represents 0.93% Increase from the current price of kr141.7.
              What do analysts say about Biotage AB?
              Biotage AB’s analyst rating consensus is a Hold. This is based on the ratings of 0 Wall Streets Analysts.
                How can I buy shares of Biotage AB?
                To buy shares of SE:BIOT, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis